1. Home
  2. DSGN vs ISTR Comparison

DSGN vs ISTR Comparison

Compare DSGN & ISTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DSGN
  • ISTR
  • Stock Information
  • Founded
  • DSGN 2017
  • ISTR 2006
  • Country
  • DSGN United States
  • ISTR United States
  • Employees
  • DSGN N/A
  • ISTR N/A
  • Industry
  • DSGN Biotechnology: Pharmaceutical Preparations
  • ISTR Major Banks
  • Sector
  • DSGN Health Care
  • ISTR Finance
  • Exchange
  • DSGN Nasdaq
  • ISTR Nasdaq
  • Market Cap
  • DSGN 208.9M
  • ISTR 189.6M
  • IPO Year
  • DSGN 2021
  • ISTR 2014
  • Fundamental
  • Price
  • DSGN $3.87
  • ISTR $21.70
  • Analyst Decision
  • DSGN Hold
  • ISTR Buy
  • Analyst Count
  • DSGN 1
  • ISTR 1
  • Target Price
  • DSGN $4.00
  • ISTR $27.00
  • AVG Volume (30 Days)
  • DSGN 92.9K
  • ISTR 32.3K
  • Earning Date
  • DSGN 08-12-2025
  • ISTR 07-21-2025
  • Dividend Yield
  • DSGN N/A
  • ISTR 2.02%
  • EPS Growth
  • DSGN N/A
  • ISTR 46.28
  • EPS
  • DSGN N/A
  • ISTR 2.24
  • Revenue
  • DSGN N/A
  • ISTR $90,347,000.00
  • Revenue This Year
  • DSGN N/A
  • ISTR $10.96
  • Revenue Next Year
  • DSGN N/A
  • ISTR $61.82
  • P/E Ratio
  • DSGN N/A
  • ISTR $9.75
  • Revenue Growth
  • DSGN N/A
  • ISTR 12.03
  • 52 Week Low
  • DSGN $2.60
  • ISTR $15.39
  • 52 Week High
  • DSGN $7.77
  • ISTR $24.81
  • Technical
  • Relative Strength Index (RSI)
  • DSGN 47.12
  • ISTR 54.13
  • Support Level
  • DSGN $3.89
  • ISTR $21.49
  • Resistance Level
  • DSGN $4.19
  • ISTR $22.70
  • Average True Range (ATR)
  • DSGN 0.23
  • ISTR 0.52
  • MACD
  • DSGN -0.02
  • ISTR -0.15
  • Stochastic Oscillator
  • DSGN 16.18
  • ISTR 17.70

About DSGN Design Therapeutics Inc.

Design Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the research and development of GeneTACTM molecules, which are a novel class of small-molecule gene-targeted chimera therapeutic candidates designed to be disease-modifying by addressing the underlying cause of diseases caused by inherited nucleotide repeat expansion mutations. The Company's product candidate is in Friedreich ataxia (FA), its second product candidate is in Fuchs endothelial corneal dystrophy (FECD), and it is also advancing its GeneTACTM program to address other serious nucleotide repeat-driven monogenic diseases.

About ISTR Investar Holding Corporation

Investar Holding Corp is a U.S.-based financial holding company. Through its subsidiaries, it offers a variety of commercial and retail lending products throughout its market areas, including business loans to small to medium-sized businesses, as well as loans to individuals. It has business operations spread across the United States and serves its customers through several service branches. The bank also offers cashiers' checks, direct deposit of payroll and Social Security checks, night depository, bank-by-mail, automated teller machines with deposit automation, and debit cards.

Share on Social Networks: